Vitamin D is the primary vitamin recommended for prostate health, particularly for men on androgen deprivation therapy (ADT)
For men with prostate cancer on ADT, maintaining adequate vitamin D levels is explicitly recommended by clinical practice guidelines to preserve bone health 1. The ESMO guidelines specifically state that men on ADT should reach and maintain reference vitamin D levels as part of lifestyle measures to prevent osteoporosis and fractures 1.
Evidence-Based Recommendations by Clinical Context
For Men on Prostate Cancer Treatment (ADT)
- Vitamin D supplementation is guideline-recommended to maintain bone health during ADT 1
- Target: Achieve and maintain reference vitamin D levels (typically >30 ng/mL)
- This is a Level IV, Grade B recommendation from major oncology guidelines 1
- ADT causes significant bone loss, and vitamin D helps mitigate fracture risk when combined with calcium intake and weight-bearing exercise
For General Prostate Cancer Prevention
The evidence is more nuanced and requires careful interpretation:
Vitamins to AVOID:
- Beta-carotene should NOT be used - it increases lung cancer risk in smokers and showed no prostate benefit 2, 3
- Vitamin E should NOT be routinely used - the SELECT trial found increased prostate cancer risk with extended follow-up 2
- Folic acid showed increased prostate cancer deaths in one trial 2
Vitamins with Potential Benefit (but insufficient evidence for routine recommendation):
Vitamin D: The most promising candidate beyond bone health
- Preclinical data suggests it may slow early-stage prostate tumor progression 4
- Shows inhibitory effects on BPH cell proliferation 5
- Recent evidence suggests optimal levels >30 ng/mL reduce disease risks 6
- However, the 2022 USPSTF guidelines conclude insufficient evidence for cancer prevention in general populations 3
B Vitamins (B1, B2, B9, B12): The most recent 2025 cross-sectional study found supplement intake of B vitamins associated with lower prostate cancer risk 7, but this is observational data requiring confirmation
Vitamin C and Zinc: Older observational data suggested protective effects 8, but this has not been confirmed in rigorous trials
Critical Caveats and Pitfalls
The calcium paradox: While vitamin D is beneficial, high calcium intake may accelerate prostate tumor progression 4. Men should maintain adequate but not excessive calcium intake.
The supplement paradox: The 2014 and 2022 USPSTF guidelines found no benefit from multivitamins or most single vitamin supplements for cancer prevention in the general population 2, 3. Most randomized trials failed to show benefit, likely because participants already had adequate baseline levels.
Context matters: The evidence differs dramatically between:
- Men with prostate cancer on treatment (vitamin D clearly indicated for bone health)
- Men with elevated PSA (antioxidants may paradoxically increase risk 9)
- Healthy men seeking prevention (insufficient evidence for routine supplementation)
Practical Algorithm
If patient has prostate cancer on ADT:
- Prescribe vitamin D supplementation (2000-4000 IU daily) to achieve levels >30 ng/mL 1, 6
- Monitor vitamin D levels
- Ensure adequate but not excessive calcium intake
- Avoid beta-carotene and vitamin E
If patient has elevated PSA or active surveillance:
- Do NOT recommend antioxidant supplements - they may increase cancer progression 9
- Focus on vitamin D for bone health only if indicated
If healthy patient seeking prevention:
- No routine vitamin supplementation is recommended for prostate cancer prevention 3
- Emphasize whole food sources rather than supplements
- If vitamin D deficiency documented (<20 ng/mL), supplement to achieve >30 ng/mL 6
The strongest evidence supports vitamin D specifically for bone health in men on ADT, not for cancer prevention per se. The general population should not take vitamin supplements expecting prostate cancer risk reduction.